Advanced course where teams of students solve challenges presented by the life science industry. Course on commercialisation of biomedical innovations. Extracurricular incubator programmes for early startup teams with coaching. Informal meeting activities across disciplines – entrepreneurs and industry sponsors, meeting with peers from university-industry. Gathering challenges at public outreach events from citizens that feed into education (synergy with outreach activity events).
Contuniously upgrading online tool box.
In Copenhagen, there are several educational initiatives and events that comprise the landscape within EIT-Health E-lab. We have curricular activities dealing with the different phases of innovation and extracurricular activities where the focus in on the entrepreneurial journey. Some of the different initiatives are briefly described here:
HealthZUp (15 ECTS)
This master level course is based on Stanford University’s Biodesign innovation process, the students will be introduced to various aspects of health and assisted living technology innovation. That includes clinical needs analysis, market analysis, ideation, prototyping, regulatory and business plan development. Lectures will be provided from different
faculties and invited guest speakers from the health technology industry. The students will work in interdisciplinary project teams that perform field studies in clinical environments. During their project industrial partners will mentor them. Students are expected to present their needs finding and screening process/ needs statement, stakeholder and market analysis, concept mapping and an early prototype to a panel of lecturers, physicians and industrial partners at the end of the course.
Advanced Biotechnology and Intellectual Property Rights (15 ECTS)
In this master level course teams of students are requested to solve challenges presented by the life science/biotech industry. Among the companies providing challenges are Lundbeck Pharma A/S and Zealand Pharma A/S. Through an eight-week course period the student teams develop solutions to the challenges and they deliver their solutions back to the companies that provided the challenges. A the end of the course the
student teams hand in a 30-pages innovation plan that include both a thorough project plan and an extensive analysis of the patent landscape around the solution.
Commercialisation of Biomedical Innovations (2,5 ECTS)
The aim of this master level course is to provide a comprehensive and
systematic overview of the most common aspects of commercialisation of Biomedical Innovations. After completion of the course, the student is expected to be able to handle a commercialisation process overall including knowledge about when to seek professional advice for more specific commercialisation activities such as patenting and negotiation.
Health Innovators (Extra-curricular)
In this student incubator programme we support student teams with a business idea both academically and commercially by offering an intensive 13-week program designed to ensure that the enterprising students take
the next, but essential steps towards the establishment of their business or implementation of their service. During the 13 weeks the following theme are addressed:
- Introduction to innovation in the health care system
- Collaboration across the health care sector
- Intellectual Property Rights
- Prototyping and test facilities
- Implementation of new solution in the health care system
- Financing a startup
In between theme sessions the teams are mentored and thereby we ensure and optimize the transition from the existing I&Efocused courses at both universities and business schools to the accelerator programmes, that exist both at a national level and in EIT-Health. The programme started the 1st of March 2017 with 15 students working in 4 teams.
Bioagora innovation across disciplines (event)
The Biomarker AGORA is an informal meeting place across disciplines, where you can share knowledge and get the a status of the broad biomarker field, be inspired to establish new collaborations, new relations, new projects, meet researchers from public institutions and private companies and patient organizations. In 2017, the biomarker agora will include a track from UCPHs EIT Health E-lab, with one key-note speaker on biomarker for dementia and with an EIT Health stand on the fair plus nomination of startups of theme interest for matchmaking at the Agora.
REBBLES: Rising Entrepreneurs in BioBusiness and Life Science (network)
The BioBusiness network was founded in 2012 by young entrepreneurs. REBBLS is the catalyst for creating the invaluable interdisciplinary network that today’s talents need for building tomorrow’s life science successes. On the 21 April, University of Copenhagen will join forces with REBBLS with a special E-lab event as a meeting place for young entrepreneurs in BioBusiness to meet with industry on a topical theme such as the humane microbiome.